Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial
Bayer
Fred Saad; Egils Vjaters; Neal Shore; David Olmos; Nianzeng Xing; Andrea Juliana Pereira de Santana Gomes; Augusto Cesar de Andrade Mota; Pamela Salman; Mindaugas Jievaltas; Albertas Ulys; Maris Jakubovskis; Evgeny Kopyltsov; Weiqing Han; Liina Nevalaita; Isabella Testa; Marie-Aude Le Berre; Iris Kuss; Kunhi Parambath Haresh; ARANOTE Study Investigators